Background: Tricuspid valve surgery has been the de facto standard treatment for tricuspid valve endocarditis (TVE) refractory to medical therapy. It is now possible to remove right-sided vegetations percutaneously using a venous drainage cannula with an extracorporeal bypass circuit.
Objectives: The purpose of our study is to describe our single-center experience of percutaneous tricuspid valve vegetation removal.
Methods: We reviewed the perioperative course of 33 consecutive patients with large tricuspid valve vegetations who carried high surgical risk.
Results: The cohort included 12 males and 21 females over a 40-month period with an average age of 37 years. A preponderance of patients carried an admitted or confirmed diagnosis of injection drug use (72.7%). Average vegetation size was 2.1 +/- 0.7 cm prior to the procedure with a 61% reduction in size after the procedure. All patients survived the procedure and 90.9% survived the index hospitalization. Three patients proceeded to elective tricuspid valve replacement due to worsening severity of tricuspid regurgitation.
Conclusion: Percutaneous removal of large tricuspid valve vegetations is a safe and effective alternative for patients with TVE who carry high-surgical risk. © 2017 Wiley Periodicals, Inc.
Keywords: AngioVac; percutaneous suction filtration; tricuspid valve endocarditis; veno-venous bypass.
© 2017 Wiley Periodicals, Inc.